STAT Plus: Tracking Washington’s moves on drug pricing

WASHINGTON — From bombastic White House speeches (and tweets) to a flurry of legislation introduced by lawmakers from both parties, it has been a whirlwind three years for policy impacting the pharmaceutical industry.

To keep track of all the fast moving developments, STAT has detailed the major proposals pending before the Trump administration and in Congress that aim to lower prescription drug prices — along with those that have already been abandoned, blocked, or softened.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Tracking Washington’s moves on drug pricing »